Changelog Master Feed From GitLab to Kilo Code (Changelog Interviews #672)
26 snips
Jan 7, 2026 
In this discussion, Sid Sijbrandij, the founder of GitLab and current CEO of Kilo.ai, shares his inspiring journey after a bone cancer diagnosis. He talks about combining treatments and innovative diagnostics from international sources to enhance his recovery. Sid also dives into his new venture, Kilo, which aims for an all-in-one coding platform that accelerates engineering productivity using agentic parallelism. He emphasizes the vital role of AI in intersecting fields and offers insights on the future of tech while managing health challenges.
AI Snips
Chapters
Transcript
Episode notes
Therapeutic Ladder Buys Time
- Sid currently has no detectable cancer but assumes microscopic disease remains and maintains a therapeutic ladder of about 30 medicines.
- He develops multiple drugs and diagnostics simultaneously to keep treatment options open.
Preserve Samples By Flash-Freezing Tissue
- Ask hospitals to flash-freeze surgical tumor samples to preserve them for later diagnostics.
- Flash-freezing retains options for advanced tests that FFPE would preclude.
Ship Fast By Empowering Individuals
- Focus on building products that let individuals move fast and ship end-to-end rather than endless coordination.
- Use AI agents and contributor communities to accelerate feature development.